Document is current

Article History

Accepted: 17 March 2021

First Online: 3 April 2021

Declarations

:

: No sources of funding were used to conduct this study or prepare this manuscript.

: MN has received honoraria for acting as a speaker from Leo Pharma. ASP is an investigator (without personal compensation) for AbbVie, AnaptysBio, Eli Lilly, Galderma, Incyte, Leo, Janssen, Novartis, and Sanofi-Regeneron and a consultant (with honorarium) for AbbVie, Amgen, Asana, Dermavant Sciences, Inc., Dermira, Galderma, Eli Lilly, Forte, Leo, Matrisys, Menlo, MorphoSys/Galapagos, Novartis, Pfizer, and Sanofi-Regeneron. TT has received honoraria for acting as a consultant and/or as a speaker from AbbVie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Eli Lilly, Janssen, Leo Pharma, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sandoz, and Sanofi.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: All authors contributed to the design and implementation of the research, to the analysis of the results, and to the writing of the manuscript.